The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells.

Octreotide is a widely used synthetic somatostatin analogue that significantly improves the management of neuroendocrine tumours (NETs). Octreotide acts through somatostatin receptors (SSTRs). However, the molecular mechanisms leading to successful disease control or symptom management, especially w...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Su-Chen Li, Cécile Martijn, Tao Cui, Ahmed Essaghir, Raúl M Luque, Jean-Baptiste Demoulin, Justo P Castaño, Kjell Öberg, Valeria Giandomenico
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2012
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/9793950de5904fd884b299674b0de96d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!